Search

Nancy Bitar

Examiner (ID: 11522, Phone: (571)270-1041 , Office: P/2669 )

Most Active Art Unit
2664
Art Unit(s)
2624, 2669, 2664
Total Applications
1250
Issued Applications
1011
Pending Applications
68
Abandoned Applications
193

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16569111 [patent_doc_number] => 20210008117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => ADIPONECTIN-EXPRESSING REGULATORY T-CELL PRECURSORS, COMPOSITION AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 16/864774 [patent_app_country] => US [patent_app_date] => 2020-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15694 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864774 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/864774
ADIPONECTIN-EXPRESSING REGULATORY T-CELL PRECURSORS, COMPOSITION AND METHODS THEREOF Apr 30, 2020 Pending
Array ( [id] => 16312619 [patent_doc_number] => 20200291357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS [patent_app_type] => utility [patent_app_number] => 16/857894 [patent_app_country] => US [patent_app_date] => 2020-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857894 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/857894
Methods and products for transfecting cells Apr 23, 2020 Issued
Array ( [id] => 17688170 [patent_doc_number] => 20220195462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 17/605486 [patent_app_country] => US [patent_app_date] => 2020-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 165198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605486 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/605486
FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS Apr 23, 2020 Pending
Array ( [id] => 19491811 [patent_doc_number] => 12110509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-08 [patent_title] => Stem cell-derived Sertoli-like cell, preparation method therefor, and use thereof [patent_app_type] => utility [patent_app_number] => 16/811086 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 7974 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811086 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/811086
Stem cell-derived Sertoli-like cell, preparation method therefor, and use thereof Mar 5, 2020 Issued
Array ( [id] => 19274603 [patent_doc_number] => 12024714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Method for preparation of retinal ganglion cells [patent_app_type] => utility [patent_app_number] => 16/808170 [patent_app_country] => US [patent_app_date] => 2020-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 55 [patent_no_of_words] => 19132 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808170 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/808170
Method for preparation of retinal ganglion cells Mar 2, 2020 Issued
Array ( [id] => 17642307 [patent_doc_number] => 20220170045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => AUGMENTATIONS TO LENTIVIRAL VECTORS (CCLC-MGATA/ANK-CORE LCR-BETA-AS3-FB) TO INCREASE EXPRESSION [patent_app_type] => utility [patent_app_number] => 17/433577 [patent_app_country] => US [patent_app_date] => 2020-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13927 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433577 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/433577
AUGMENTATIONS TO LENTIVIRAL VECTORS (CCLC-MGATA/ANK-CORE LCR-BETA-AS3-FB) TO INCREASE EXPRESSION Feb 26, 2020 Pending
Array ( [id] => 16513283 [patent_doc_number] => 20200392541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY [patent_app_type] => utility [patent_app_number] => 16/800988 [patent_app_country] => US [patent_app_date] => 2020-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 126749 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800988 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/800988
Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy Feb 24, 2020 Issued
Array ( [id] => 17719064 [patent_doc_number] => 20220211783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/610661 [patent_app_country] => US [patent_app_date] => 2020-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/610661
GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER Feb 23, 2020 Abandoned
Array ( [id] => 16539469 [patent_doc_number] => 20200405882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => RECOMBINANT ADENO-ASSOCIATED VECTORS FOR TARGETED TREATMENT [patent_app_type] => utility [patent_app_number] => 16/787980 [patent_app_country] => US [patent_app_date] => 2020-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787980 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/787980
Recombinant adeno-associated vectors for targeted treatment Feb 10, 2020 Issued
Array ( [id] => 15993983 [patent_doc_number] => 20200172862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS [patent_app_type] => utility [patent_app_number] => 16/782772 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -74 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782772 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/782772
METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS Feb 4, 2020 Pending
Array ( [id] => 15931741 [patent_doc_number] => 20200157504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS [patent_app_type] => utility [patent_app_number] => 16/776765 [patent_app_country] => US [patent_app_date] => 2020-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16776765 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/776765
Methods and products for transfecting cells Jan 29, 2020 Issued
Array ( [id] => 15963637 [patent_doc_number] => 20200165570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => METHODS FOR REPROGRAMMING CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/752462 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752462 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/752462
METHODS FOR REPROGRAMMING CELLS AND USES THEREOF Jan 23, 2020 Abandoned
Array ( [id] => 18718104 [patent_doc_number] => 11795439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Methods for reprogramming cells and uses thereof [patent_app_type] => utility [patent_app_number] => 16/752535 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 63166 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752535 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/752535
Methods for reprogramming cells and uses thereof Jan 23, 2020 Issued
Array ( [id] => 17520722 [patent_doc_number] => 20220106571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => CHOROID PLEXUS ORGANOIDS AND METHODS FOR PRODUCTION THEREOF [patent_app_type] => utility [patent_app_number] => 17/425043 [patent_app_country] => US [patent_app_date] => 2020-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21762 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425043 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/425043
Choroid plexus organoids and methods for production thereof Jan 22, 2020 Issued
Array ( [id] => 16107863 [patent_doc_number] => 20200205954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-02 [patent_title] => METHODS FOR USE OF SEX SORTED SEMEN TO IMPROVE GENETIC MANAGEMENT IN SWINE [patent_app_type] => utility [patent_app_number] => 16/747406 [patent_app_country] => US [patent_app_date] => 2020-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747406 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/747406
Methods for use of sex sorted semen to improve genetic management in swine Jan 19, 2020 Issued
Array ( [id] => 17292476 [patent_doc_number] => 20210388315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => ISOLATION AND CULTIVATION OF MUSCLE AND FAT CELLS FROM CRUSTACEANS [patent_app_type] => utility [patent_app_number] => 17/422596 [patent_app_country] => US [patent_app_date] => 2020-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422596 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422596
ISOLATION AND CULTIVATION OF MUSCLE AND FAT CELLS FROM CRUSTACEANS Jan 12, 2020 Abandoned
Array ( [id] => 16435686 [patent_doc_number] => 20200353011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => METHODS FOR MAKING AND USING SINOATRIAL NODE-LIKE PACEMAKER CARDIOMYOCYTES AND VENTRICULAR-LIKE CARDIOMYOCYTES [patent_app_type] => utility [patent_app_number] => 16/737768 [patent_app_country] => US [patent_app_date] => 2020-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737768 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/737768
Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes Jan 7, 2020 Issued
Array ( [id] => 17457879 [patent_doc_number] => 20220071183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM [patent_app_type] => utility [patent_app_number] => 17/417829 [patent_app_country] => US [patent_app_date] => 2020-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417829 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/417829
ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM Jan 6, 2020 Abandoned
Array ( [id] => 16238213 [patent_doc_number] => 20200255447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => THIENOPYRIMIDINES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/734892 [patent_app_country] => US [patent_app_date] => 2020-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734892 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/734892
THIENOPYRIMIDINES AND USES THEREOF Jan 5, 2020 Abandoned
Array ( [id] => 15862937 [patent_doc_number] => 20200138872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS [patent_app_type] => utility [patent_app_number] => 16/715597 [patent_app_country] => US [patent_app_date] => 2019-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/715597
METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS Dec 15, 2019 Abandoned
Menu